# L-CARnitine in the Palliative Treatment of Advanced PANcreatic Cancer (CARPAN)

> **NCT01330823** · PHASE3 · SUSPENDED · sponsor: **University Medicine Greifswald** · enrollment: 72 (actual)

## Conditions studied

- Pancreatic Carcinoma

## Interventions

- **DIETARY_SUPPLEMENT:** L-Carnitine
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01330823
- **Lead sponsor:** University Medicine Greifswald
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2006-06
- **Primary completion:** 2009-10
- **Final completion:** 2010-07
- **Target enrollment:** 72 (ACTUAL)
- **Why stopped:** after interims analysis standard errors for inflammatory and nutritional markers varied widely, that the power calculation required unattainable goals
- **Last updated:** 2011-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01330823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01330823, "L-CARnitine in the Palliative Treatment of Advanced PANcreatic Cancer (CARPAN)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01330823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*